Hims & Hers’ earnings soar while GLP-1 drug crisis deepens—what this means for investors

By on    Pharma Industry News  

Hims & Hers’ earnings soar while GLP-1 drug crisis deepens—what this means for investors

Hims & Hers Health Inc. saw its stock surge following a robust quarterly earnings report, which showcased significant growth in revenue and subscriber numbers. Despite the rally, the company faces an ongoing challenge with GLP-1 drug shortages, a critical component in its expanding weight-loss solutions. Executives from Hims & Hers indicated that the scarcity of […]

FDA approves Novo Nordisk’s Wegovy for cardiovascular risk reduction in adults with obesity

By on    Pharma Industry News  

FDA approves Novo Nordisk’s Wegovy for cardiovascular risk reduction in adults with obesity

The U.S. Food and Drug Administration (FDA) has recently granted an additional indication for Novo Nordisk’s Wegovy, a milestone in medical advancements aimed at combating cardiovascular diseases (CVD). This new approval positions Wegovy as the first treatment option specifically approved to reduce the risk of major cardiovascular events such as death, heart attack, or stroke […]